Last update 21 Nov 2024

MTC-01

Overview

Basic Info

Drug Type
Microbiota
Synonyms
Target-
Mechanism
Bacteria replacements, Microbiome modulators
Therapeutic Areas
NeoplasmsInfectious DiseasesEndocrinology and Metabolic Disease+ [1]
Active Indication
Clostridioides difficile infection recurrenceThyroid Cancer, Medullary
Inactive Indication-
Originator Organization
Icahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai
Active Organization
National Institute of Diabetes & Digestive & Kidney DiseasesNational Institute of Diabetes & Digestive & Kidney DiseasesIcahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with MTC-01
NCT05911997 / RecruitingPhase 1IIT
Comparison of MTC01 vs FMT for the Treatment of Recurrent Clostridioides Difficile Infection
EUCTR2007-002470-59-GB / Not yet recruitingNot Applicable
AN OPEN LABEL CONTINUATION STUDY OF THE EFFECTS OF MTC 30 MG TID AND 60 MG TID IN PATIENTS WITH ALZHEIMER’S DISEASE - Open Label Study of Methylthioninium Chloride (MTC) in Alzheimer’s Disease
EUCTR2005-005915-13-GB / Not yet recruitingPhase 2
An Open Pilot Study of Methlythioninium Chloride (MTC) in Frontotemporal Dementia and Related Dementia Syndromes - Pilot Stidy of MTC in FTD and related dementia syndromes
100 Clinical Results associated with MTC-01
Login to view more data
100 Translational Medicine associated with MTC-01
Login to view more data
100 Patents (Medical) associated with MTC-01
Login to view more data
100 Deals associated with MTC-01
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Clostridioides difficile infection recurrencePhase 1
US
National Institute of Diabetes & Digestive & Kidney DiseasesNational Institute of Diabetes & Digestive & Kidney Diseases
08 Jan 2024
Clostridioides difficile infection recurrencePhase 1
US
Icahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai
08 Jan 2024
Thyroid Cancer, MedullaryPhase 1
US
National Institute of Diabetes & Digestive & Kidney DiseasesNational Institute of Diabetes & Digestive & Kidney Diseases
08 Jan 2024
Thyroid Cancer, MedullaryPhase 1
US
Icahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai
08 Jan 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free